Results 41 to 50 of about 344,007 (291)
npj Digital Medicine, 2018 Artificial Intelligence (AI) has long promised to increase healthcare affordability, quality and accessibility but FDA, until recently, had never authorized an autonomous AI diagnostic system.
M. Abràmoff +4 more
semanticscholar +1 more source
IDRiD: Diabetic Retinopathy - Segmentation and Grading Challenge.
Medical Image Analysis, 2020 Diabetic Retinopathy (DR) is the most common cause of avoidable vision loss, predominantly affecting the working-age population across the globe. Screening for DR, coupled with timely consultation and treatment, is a globally trusted policy to avoid ...
Prasanna Porwal +56 more
semanticscholar +1 more source
IEEE Journal of Translational Engineering in Health and Medicine, 2023 Objective: Diabetic Retinopathy (DR) is a retinal disease that can cause damage to blood vessels in the eye, that is the major cause of impaired vision or blindness, if not treated early.
Ghulam Ali +4 more
semanticscholar +1 more source
Oxidative Stress and Its Regulation in Diabetic Retinopathy
Antioxidants, 2023 Diabetic retinopathy is the retinal disease associated with hyperglycemia in patients who suffer from type 1 or type 2 diabetes. It includes maculopathy, involving the central retina and characterized by ischemia and/or edema, and peripheral retinopathy ...
Cameron D. Haydinger +3 more
semanticscholar +1 more source
Frontiers in Pharmacology, 2021 To investigate the role of vascular endothelial growth factor (VEGF) at different phases of diabetic retinopathy (DR), we assessed the retinal protein expression of VEGF-A164 (corresponding to the VEGF165 isoform present in humans, which is the ...
Claudio Bucolo +10 more
doaj +1 more source
Research progress on the pathogenesis of diabetic retinopathy
BMC Ophthalmology, 2023 Diabetic retinopathy is one of the most common and serious microvascular complications of diabetes mellitus. There are many factors leading to diabetic retinopathy, and its pathogenesis is still unclear.
Hong-Bo Li +6 more
semanticscholar +1 more source
Screening for diabetic retinopathy: new perspectives and challenges.
The Lancet Diabetes and Endocrinology, 2020 Although the prevalence of all stages of diabetic retinopathy has been declining since 1980 in populations with improved diabetes control, the crude prevalence of visual impairment and blindness caused by diabetic retinopathy worldwide increased between ...
S. Vujosevic +6 more
semanticscholar +1 more source
The Lancet Digital Health, 2022 BACKGROUND Diabetic retinopathy is a leading cause of preventable blindness, especially in low-income and middle-income countries (LMICs). Deep-learning systems have the potential to enhance diabetic retinopathy screenings in these settings, yet ...
P. Ruamviboonsuk +16 more
semanticscholar +1 more source
Frontiers in Medicine, 2021 Objective: To detect retinal involvement in coronavirus disease 2019 (COVID-19) patients in acute and convalescent phase by their fundus screening.Methods: In a prospective, cross-sectional, observational study (July–November 2020), 235 patients (142 ...
Reema Bansal +14 more
doaj +1 more source
Deep Learning Techniques For Diabetic Retinopathy Classification: A Survey
IEEE Access, 2022 Diabetic Retinopathy (DR) is a degenerative disease that impacts the eyes and is a consequence of Diabetes mellitus, where high blood glucose levels induce lesions on the eye retina.
Mohammad Z. Atwany +2 more
semanticscholar +1 more source